Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4',5,7-trihydroxyflavanone 7-rhamnoglucoside
2. Aurantiin
3. Cyclorel
4. Naringenin-7-hesperidoside
5. Naringin Dihydrochalcone
6. Naringin Sodium
1. 10236-47-2
2. Naringoside
3. Aurantiin
4. Naringenin 7-o-neohesperidoside
5. 4'5-dioh-flavone-7-rhgluc
6. Chembl451532
7. N7td9j649b
8. (2s)-7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
9. Chebi:28819
10. Naringenin 7-rhamnoglucoside
11. (s)-7-(((2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
12. 7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
13. Naringenin 7-o-[alpha-l-rhamnosyl-(1->2)-beta-d-glucoside]
14. Mfcd00148888
15. (2s)-naringin
16. Naringenine-7-rhamnosidoglucoside
17. Sr-01000736681
18. Unii-n7td9j649b
19. Naringenin,(s)
20. Naringenin-7-beta-neohesperidoside
21. (s)-7-((2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2-yloxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
22. Einecs 233-566-4
23. Naringin (naringoside)
24. Naringin [inci]
25. Ai3-19008
26. Naringin [mi]
27. 132203-74-8
28. Prestwick0_000467
29. Prestwick1_000467
30. Prestwick2_000467
31. Prestwick3_000467
32. Naringin [usp-rs]
33. Aurantiin [who-dd]
34. Schembl23432
35. Bspbio_000574
36. Cid_25075
37. Mls000069459
38. Bidd:er0262
39. Divk1c_000247
40. Spbio_002513
41. Bpbio1_000632
42. Cid_442428
43. Gtpl4738
44. Megxp0_001877
45. Naringin Extract [fhfi]
46. Dtxsid6022478
47. Acon1_000139
48. Hms500m09
49. Kbio1_000247
50. Ninds_000247
51. Citrus Naringinine [vandf]
52. Hms2231m18
53. Hy-n0153
54. Zinc8143604
55. Bdbm50241582
56. S2329
57. Akos016034302
58. Ccg-208591
59. Cs-5632
60. Idi1_000247
61. Ncgc00142617-01
62. Ncgc00142617-02
63. Ncgc00142617-03
64. 5-hydroxy-2-(4-hydroxyphenyl)-7-(2-o-alpha-l-rhamnopyranosyl-beta-d-glucopyranosyloxy)-4-chromanon
65. 7-(2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyloxy)-2,3-dihydro-4',5,7-trihydroxyflavone
66. As-12929
67. Smr000059108
68. Xn167836
69. N2371
70. 4',5,7-trihydroxyflavanone-7-rhamnoglucoside
71. C09789
72. 236n472
73. A800566
74. Q418469
75. Sr-01000736681-4
76. Sr-01000736681-5
77. Brd-k02953697-001-09-2
78. Brd-k02953697-002-03-3
79. Naringenin 7-o-alpha-l-rhamnosyl-(1->2)-beta-d-glucoside
80. Naringenin 7-o-(alpha-l-rhamnosyl-(1,2)-beta-d-glucoside)
81. (2s)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2h-chromen-7-yl 2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
82. (2s)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2h-chromen-7-yl 2-o-(6-deoxy-alpha-l-mannopyranosyl)-betad-glucopyranoside
83. (2s)-7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
84. (2s)-7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
85. (2s)-7-[(2s,4s,5s,3r,6r)-3-((2s,6s,3r,4r,5r)-3,4,5-trihydroxy-6-methyl(2h-3,4, 5,6-tetrahydropyran-2-yloxy))-4,5-dihydroxy-6-(hydroxymethyl)(2h-3,4,5,6-tetra Hydropyran-2-yloxy)]-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
86. (2s)-7-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-one
87. (s)-7-((2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydro-2h-pyran-2-yloxy)-tetrahydro-2h-pyran-2-yloxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
88. 4h-1-benzopyran-4-one, 7-((2-o-(6-deoxy-alpha-l-mannapyranosyl)-beta-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl), (s)-
89. 4h-1-benzopyran-4-one, 7-((2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (2s)-
90. 4h-1-benzopyran-4-one,7-[[2-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-,(s)-
91. 7-((2-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
92. 7-(2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyloxy)-2,3-dihydro-4,5,7-trihydroxyflavone;naringin
93. 7-[[2-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-5-hydroxy-2(s)-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
| Molecular Weight | 580.5 g/mol |
|---|---|
| Molecular Formula | C27H32O14 |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 6 |
| Exact Mass | 580.17920569 g/mol |
| Monoisotopic Mass | 580.17920569 g/mol |
| Topological Polar Surface Area | 225 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 884 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
57
PharmaCompass offers a list of Naringin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naringin manufacturer or Naringin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naringin manufacturer or Naringin supplier.
PharmaCompass also assists you with knowing the Naringin API Price utilized in the formulation of products. Naringin API Price is not always fixed or binding as the Naringin Price is obtained through a variety of data sources. The Naringin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside, including repackagers and relabelers. The FDA regulates Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside supplier is an individual or a company that provides Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside active pharmaceutical ingredient (API) or Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside finished formulations upon request. The Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside suppliers may include Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside API manufacturers, exporters, distributors and traders.
click here to find a list of Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside GMP manufacturer or Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside GMP API supplier for your needs.
A Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside CoA (Certificate of Analysis) is a formal document that attests to Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside's compliance with Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside specifications and serves as a tool for batch-level quality control.
Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside CoA mostly includes findings from lab analyses of a specific batch. For each Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside may be tested according to a variety of international standards, such as European Pharmacopoeia (Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside EP), Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naringin, Naringoside, Naringenine-7-rhamnosidoglucoside USP).
